Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Yoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 108.7K citations

Natural Sciences, Biostatistics, A/b Testing +13

ECDEU Assessment Manual for Psychopharmacology

William Guy · Bulletin of Miscellaneous Information (Royal Gardens Kew) · 1976 · 8.8K citations

Medicine, Pharmacology, Psychiatry +7

Fibromyalgia Criteria and Severity Scales for Clinical and Epidemiological Studies: A Modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia

Frederick Wolfe, Daniel J. Clauw, Mary‐Ann Fitzcharles et al. · The Journal of Rheumatology · 2011 · 1.5K citations · Full text

Medicine, Internal Medicine, Health Assessment +16

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations

Medicine, Neurology, Pharmacology +9

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Anne‐Marie Malfait, Ruth Gallily, Percy F. Sumariwalla et al. · Proceedings of the National Academy of Sciences · 2000 · 663 citations

Medicine, Pharmacology, Pharmacotherapy +15